REG - Kromek Group PLC - Grant of Long-Term Incentives
04/06/2026 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260604:nRSD9134Ga&default-theme=true
RNS Number : 9134G Kromek Group PLC 04 June 2026
4 June 2026
Kromek Group plc
("Kromek", the "Company" or the "Group")
Grant of Long-Term Incentives
Kromek (AIM: KMK), a global detection company delivering best-in-class
solutions for the advanced imaging and CBRN detection markets, announces the
grant of performance-based share awards under its Long-Term Incentive Plan
(the "LTIP") to Executive Directors of the Company.
The Company has granted a total of 15,566,498 share awards under its LTIP in
the form of options over ordinary shares of 1p each in the Company ("Ordinary
Shares") that vest subject to the achievement of certain performance criteria
(the "LTIP Awards") assessed over the three financial years ending 30 April
2028. The LTIP Awards have a nominal value exercise price of 1p per Ordinary
Share. The LTIP Awards have been granted to Directors of the Company as
follows:
Director No. of LTIP Awards
Arnab Basu, CEO 7,640,437
Claire Burgess, CFO 2,458,256
Berry Beumer, COO 5,467,805
The LTIP Awards will vest subject to the Company meeting a minimum relative
total shareholder return ("RTSR") equal to the FTSE AIM All-Share Index
Average Total Shareholder Return ("TSR") over the performance period. 25% of
the LTIP Awards will vest on meeting this minimum threshold performance
criteria, with vesting thereafter on a straight-line basis up to meeting a
maximum performance target of a RTSR that is 30% greater than the FTSE AIM
All-Share Index Average TSR.
Once vested, the LTIP Awards may be exercised at any time until the seventh
anniversary of the vest date. The vest date is the last day of the performance
period if, and to the extent that, the performance criteria has been met and
subsequently ratified by the Board.
Accordingly, as at 3 June 2026, the Company had options and LTIPs outstanding
over a total of 76,635,732 Ordinary Shares, representing 11.7% of the
Company's issued share capital, and PDMRs/Directors had the following
interest in the Company's issued share capital:
Director No. of Ordinary Shares Vested Options and LTIPs Unvested Options and LTIPs
Options LTIPs Options LTIPs
Arnab Basu 3,198,750 8,912,308 7,500,000 375,000 13,557,332
Claire Burgess - - - 2,500,000 1,229,128
Berry Beumer 230,000 6,984,570 5,696,350 375,000 9,974,542
Rakesh Sharma 1,310,208 59,033 - - -
Christopher Wilks 277,941 31,104 - - -
Matt Boyle 285,000 - - - -
Enquiries
Kromek Group plc
Arnab Basu, CEO +44 (0)1740 626 060
Claire Burgess, CFO
Cavendish Capital Markets Limited (Nominated Adviser and Broker)
Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance +44 (0)20 7220 0500
Andrew Burdis - ECM
Michael Johnson - Sales
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury +44 (0)20 4582 3500
Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and
bio-detection technology solutions for the advanced imaging and CBRN detection
segments. Headquartered in County Durham, UK, Kromek has manufacturing
operations in the UK and US, delivering on the vision of enhancing the quality
of life through innovative detection technology solutions.
The advanced imaging segment comprises the medical (including CT and SPECT),
security and industrial markets. Kromek provides its OEM customers with
detector components, based on its core cadmium zinc telluride (CZT) platform,
to enable better detection of diseases such as cancer and Alzheimer's,
contamination in industrial manufacture and explosives in aviation
settings.
In CBRN detection, the Group provides nuclear radiation detection solutions
to the global homeland defence and security market. Kromek's compact,
handheld, high-performance radiation detectors, based on advanced
scintillation and solid-state readout technology, are primarily used to
protect critical infrastructure, events, personnel and urban environments from
the threat of 'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN detection
segment. These consist of fully automated and autonomous systems to detect a
wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange, under the
trading symbol 'KMK'.
Notification and public disclosure of transactions by persons discharging managerial
responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Arnab Basu
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction Grant of options under Long-Term Incentive Plan
c) Price(s) and volume(s)
Price(s) Volume(s)
1p 7,640,437
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 2 June 2026
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Claire Burgess
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction Grant of options under Long-Term Incentive Plan
c) Price(s) and volume(s)
Price(s) Volume(s)
1p 2,458,256
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 2 June 2026
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Berry Beumer
2 Reason for the notification
a) Position/status Chief Operating Officer and President of the Advanced Imaging Division
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction Grant of options under Long-Term Incentive Plan
c) Price(s) and volume(s)
Price(s) Volume(s)
1p 5,467,805
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 2 June 2026
f) Place of the transaction Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBIGDLLDGDGLX
Copyright 2019 Regulatory News Service, all rights reservedRecent news on Kromek
See all newsREG - AIM - AIM Notice - 04/06/2026
AnnouncementREG - Kromek Group PLC - Grant of Long-Term Incentives
AnnouncementRCS - Kromek Group PLC - Launch of new interactive investor hub
AnnouncementREG - Kromek Group PLC - PDMR/Director Shareholding, Issue of Equity & TVR
AnnouncementREG - Kromek Group PLC - Full Year 2026 Trading Update
Announcement